|
US$279.00 ยท In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
GB/T 42218-2022: Clinical laboratory medicine - In vitro diagnostic medical devices - Validation of user quality control procedures by the manufacturer
Status: Valid
| Standard ID | Contents [version] | USD | STEP2 | [PDF] delivered in | Standard Title (Description) | Status | PDF |
| GB/T 42218-2022 | English | 279 |
Add to Cart
|
3 days [Need to translate]
|
Clinical laboratory medicine - In vitro diagnostic medical devices - Validation of user quality control procedures by the manufacturer
| Valid |
GB/T 42218-2022
|
PDF similar to GB/T 42218-2022
Basic data | Standard ID | GB/T 42218-2022 (GB/T42218-2022) | | Description (Translated English) | Clinical laboratory medicine - In vitro diagnostic medical devices - Validation of user quality control procedures by the manufacturer | | Sector / Industry | National Standard (Recommended) | | Classification of Chinese Standard | C30 | | Classification of International Standard | 11.100.10 | | Word Count Estimation | 14,134 | | Date of Issue | 2022-12-30 | | Date of Implementation | 2023-07-01 | | Issuing agency(ies) | State Administration for Market Regulation, China National Standardization Administration | GB/T 42218-2022: Clinical laboratory medicine - In vitro diagnostic medical devices - Validation of user quality control procedures by the manufacturer
---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
ICS 11.100.10
CCSC30
National Standards of People's Republic of China
Laboratory Medicine In Vitro Diagnostic Medical Devices
The manufacturer's quality control for the user
program confirmation
(ISO 15198.2004, MOD)
Posted on 2022-12-30
2023-07-01 implementation
State Administration for Market Regulation
Released by the National Standardization Management Committee
table of contents
Preface III
Introduction IV
1 Scope 1
2 Normative references 1
3 Terms and Definitions 1
4 Quality Control Procedures 4
5 Validation of quality control procedures 5
6 Advice to users6
Reference 7
foreword
This document is in accordance with the provisions of GB/T 1.1-2020 "Guidelines for Standardization Work Part 1.Structure and Drafting Rules for Standardization Documents"
drafting.
This document is modified to adopt ISO 15198.2004 "Quality control provided to users by manufacturers of in vitro diagnostic medical devices for laboratory medicine".
Confirmation of Manufacturing Procedures.
Compared with ISO 15198.2004, this document has made the following structural adjustments.
--- Deleted 3.3, 3.7, 3.12, 3.16~3.20, 3.23 of ISO 15198.2004;
--- Merge 3.10 and 3.11 of ISO 15198.2004 into one term.
The technical differences between this document and ISO 15198.2004 and their reasons are as follows.
--- Deleted the normative references ISO 3534-1, ISO 5725-1, added GB/T 29791.1, JJF1001 (see Chapter 3).
---The basic vocabulary and common terms of international metrology (VIM), BIPM, IEC, IFCC, ISO, IUPAC, IUPAP,
OIML, the second edition is replaced by ISO /IEC Guide 99 to adapt to the national conditions of our country.
---Change the term names and contents originally quoted in 3.2, 3.4~3.6, 3.8~3.11, 3.22, 3.24~3.26 to GB/T 29791.1-
The corresponding term names and contents in.2013 are adapted to my country's national conditions.
--- 3.1, 3.14, adopt the definition of terms in JJF1001-2011, 3.13 adopt the definition of ISO 13485.2016, 3.21 adopt
The definition in ISO 14971.2019 to adapt to my country's national conditions.
Please note that some contents of this document may refer to patents. The issuing agency of this document assumes no responsibility for identifying patents.
This document is proposed by the State Drug Administration.
This document is under the jurisdiction of the National Medical Clinical Laboratory and In Vitro Diagnostic System Standardization Technical Committee (SAC/TC136).
This document was drafted by. Beijing Institute of Medical Device Inspection (Beijing Medical Biological Protection Equipment Inspection and Research Center), Beijing Jinyu
Medical Testing Laboratory Co., Ltd., Beijing Tiantan Hospital Affiliated to Capital Medical University, Shandong Aikeda Biotechnology Co., Ltd., Beijing Zhongguan
Village Shuimu Medical Technology Co., Ltd., Beijing Jiuqiang Biotechnology Co., Ltd., Beijing Leadman Biochemical Co., Ltd., Beijing Huake
Thai Biotechnology Co., Ltd., Dirui Medical Device Technology Co., Ltd.
The main drafters of this document. Yang Zhong, Chen Baorong, Zhang Guojun, Zou Yingshu, Li Jian, Wang Jun, Chen Yang, Ren Yikun, Xiao Yi, Chang Shuqin, Chen Wei.
Introduction
Manufacturers of in vitro diagnostic medical devices usually incorporate quality control procedures into their instructions for use. The quality control program serves to provide
Provide the user with assurance that the device will perform as specified so that the results are consistent with the intended diagnostic use. For some medical devices, quality control
Procedures may be an essential risk control measure. Through the design of the medical device quality control program, the quality control program can also be passed
The following aspects help users ensure the quality of results.
a) verify the suitability of the analytical system (sample, reagents, instrument and/or operator);
b) monitoring the precision and correctness of measurement results;
c) prevent false negative and false positive results;
d) identify fault conditions that may lead to inaccurate results; and/or
e) Eliminate faults requiring corrective action.
In addition, manufacturers usually design in vitro diagnostic medical devices so that they can detect potential failures and warn users to take corrective actions.
ability to measure. These internal control systems can potentially reduce or even eliminate the need for users to run quality control samples to monitor device performance.
need.
This document can be used as part of the design controls and risk management program for manufacturers of in vitro diagnostic medical devices. This document also enables manufacturers to
Provides validated quality control procedures for clinical diagnostic laboratory users.
This document describes how manufacturers can validate the quality control procedures for their devices. Validation procedures ensure that the manufacturer is running quality controls as intended.
control procedures, and to ensure that the manufacturer's recommendations meet certain special medical devices, such as separation systems, products with built-in electronic controllers, and devices
The need for products with chemical and/or biological controls. Information on validated quality control procedures enhances user confidence in the overall quality of the device
Understanding of quality assurance requirements and making informed choices about appropriate control procedures.
Although laboratory directors are ultimately responsible for determining appropriate quality control procedures for their laboratory, in vitro diagnostic medical device
Manufacturers are responsible for providing users with sufficient information on device performance, risk control methods, and performance verification methods in the instructions. because
Thus, in fact, quality control is a shared responsibility of both the manufacturer and user of in vitro diagnostic medical devices.
Due to the essential differences in design, technology, function and intended use of in vitro diagnostic medical devices, no matter now or in the future,
No single quality control program will cover all IVD medical devices. Established quality control practices over the years have provided the laboratory with
provides some level of assurance that the results are valid. Although these quality controls have been widely accepted by laboratories, regulatory agencies, and accreditation bodies
Practice, but these practices originated from the manual operation of laboratory analysis and the stage of laboratory self-preparation of reagents. Regarding current in vitro diagnostic medical devices
However, they may not always be optimal. Therefore, when a quality control program is required, it is the responsibility of the manufacturer to design and validate
Appropriate quality control procedures.
Quality system standards for medical device manufacturers are evolving with the times. For example, ISO 13485 and most regulations at the time included design
control and risk management requirements. Design control requires a risk analysis of the design, and requires that the design meet the user requirements before the product is released to the market.
identified in terms of user requirements and intended use. Quality control procedures in instructions for use are considered inseparable from the design of in vitro diagnostic medical devices
Therefore, it is necessary to design the confirmed requirements.
Laboratory Medicine In Vitro Diagnostic Medical Devices
The manufacturer's quality control for the user
program confirmation
1 Scope
This document describes the process by which manufacturers of in vitro diagnostic medical devices validate quality control procedures recommended to users. Quality Control Procedures
The purpose of the test is to provide the user with assurance that the performance of the device is consistent with its intended use and the manufacturer's declaration.
This document applies to all in vitro diagnostic medical devices.
2 Normative references
The contents of the following documents constitute the essential provisions of this document through normative references in the text. Among them, dated references
For documents, only the version corresponding to the date is applicable to this document; for undated reference documents, the latest version (including all amendments) is applicable to
this document.
GB/T 29791.1 Information provided by manufacturers of in vitro diagnostic medical devices (labelling) Part 1.Terms, definitions and general requirements
Seek (GB/T 29791.1-2013, ISO 18113-1.2009, IDT)
ISO 13485 medical device quality management system for regulatory requirements (Medicaldevices-Qualitymanagement
Note. YY/T 0287-2017 Medical Device Quality Management System is used for regulatory requirements (ISO 13485.2016, IDT)
Note. Application of YY/T 0316-2016 Medical Device Risk Management to Medical Devices (ISO 14971.2007 Corrected Edition, IDT)
JJF1001 General Metrology Terms and Definitions
3 Terms and Definitions
GB/T 29791.1, ISO 13485, ISO 14971, JJF1001, ISO /IEC Guide 99 and the following terms and definitions apply
used in this document.
3.1
Accuracyaccuracy
The degree of agreement between the measured value of a measurand and its true value.
[Source. JJF1001-2011,5.8]
3.2
bias
An estimate of the systematic measurement error.
[Source. GB/T 29791.1-2013, A.3.25]
Tips & Frequently Asked Questions:Question 1: How long will the true-PDF of GB/T 42218-2022_English be delivered?Answer: Upon your order, we will start to translate GB/T 42218-2022_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time. Question 2: Can I share the purchased PDF of GB/T 42218-2022_English with my colleagues?Answer: Yes. The purchased PDF of GB/T 42218-2022_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet. Question 3: Does the price include tax/VAT?Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countriesQuestion 4: Do you accept my currency other than USD?Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.
|